Correction to: Cost-Effectiveness of Imipenem/Cilastatin/Relebactam Compared with Colistin in Treatment of Gram-Negative Infections Caused by Carbapenem-Non-Susceptible Organisms

Infect Dis Ther. 2022 Aug;11(4):1459-1460. doi: 10.1007/s40121-022-00660-6.
No abstract available

Publication types

  • Published Erratum